(RTTNews) - Eli Lilly and Co. (LLY) announced that its Ebglyss monotherapy monthly injection demonstrated sustained and deep responses in patients with moderate-to-severe atopic dermatitis over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback